Skip to main content
Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
106.15
-0.23 (-0.22%)
At close: Apr 24, 2025, 4:00 PM
102.52
-3.63 (-3.42%)
After-hours: Apr 24, 2025, 6:03 PM EDT

Gilead Sciences Product Revenue by Segment
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
HIV
19.86B 19.61B 18.85B 18.45B 18.33B 18.18B 18.26B 18.08B
HIV Growth
8.34% 7.90% 3.28% 2.06% 3.68% 5.71% 7.64% 8.48%
Oncology
3.26B 3.29B 3.21B 3.16B 3.05B 2.93B 2.78B 2.59B
Oncology Growth
6.75% 12.18% 15.46% 22.16% 27.71% 37.07% 47.77% 59.19%
Liver Disease
3.04B 3.02B 2.99B 2.97B 2.85B 2.78B 2.79B 2.87B
Liver Disease Growth
6.92% 8.55% 7.43% 3.42% 0.21% -0.57% 0.83% 8.19%
Veklury
1.55B 1.80B 2.18B 2.13B 2.17B 2.19B 2.47B 2.75B
Veklury Growth
-28.70% -17.71% -11.52% -22.84% -26.37% -44.05% -42.16% -47.64%
Other
874.00M 889.00M 906.00M 921.00M 884.00M 859.00M 910.00M 894.00M
Other Growth
-1.13% 3.49% -0.44% 3.02% -2.54% -9.00% -3.40% -9.42%

Revenue by Type
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Product
28.58B 28.61B 28.14B 27.62B 27.28B 26.93B 27.20B 27.18B
Product Growth
4.77% 6.22% 3.48% 1.63% 1.94% -0.18% 1.44% -0.03%
Other
158.00M 143.00M 155.00M 181.00M 175.00M 182.00M 193.00M 201.00M
Other Growth
-9.71% -21.43% -19.69% -9.95% -39.24% -38.93% -40.80% -38.53%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.